Clinical and microbiological characteristics of Pantoea agglomerans infection in children

Ayşe Büyükcam1, Özlem Tuncer2, Deniz Gür2

  • 1Pediatric Infectious Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Insights

Pantoea agglomerans infections, though rare in children, can be severe, particularly pneumonia in those with comorbidities. Carbapenem-resistant strains are linked to mortality, highlighting the need for further research into drug resistance.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Clinical Bacteriology

Background:

  • Pantoea agglomerans is an environmental Gram-negative bacterium.
  • It rarely causes human infections but is linked to occupational diseases.
  • Its role in pediatric infections is not well-defined.

Purpose of the Study:

  • To evaluate the clinical and microbiological characteristics of Pantoea agglomerans infections in children.
  • To assess the pathogenicity and outcomes of P. agglomerans in a pediatric population.
  • To identify risk factors and common infection types associated with P. agglomerans.

Main Methods:

  • Retrospective review of pediatric hospital records (January 2000-June 2015).
  • Inclusion criteria: patients aged 1 month to 18 years with positive P. agglomerans cultures.
  • Identification methods included conventional tests, BBL Crystal E/NF ID, and MALDI-TOF MS. Antibiotic susceptibility testing used the Kirby-Bauer method.

Main Results:

  • Fifteen positive cultures from 14 pediatric patients were identified.
  • Common infection sites included wound infections (35.7%), pneumonia (21.4%), and urinary tract infections (21.4%).
  • Three patients (21.4%) died, all with carbapenem-resistant P. agglomerans, particularly in cases of pneumonia.

Conclusions:

  • Pantoea agglomerans infections can be life-threatening in children, especially those with pneumonia and underlying comorbidities.
  • Carbapenem resistance is a significant factor in mortality.
  • Further research is needed to understand hospital-acquired P. agglomerans pathogenicity and drug-resistance patterns.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
501
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
830
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
982
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
963